| ²é¿´: 152 | »Ø¸´: 1 | |||
baoxianxieľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
΢Æ×¼±Çó£¡ÍûÖÁÉÙ¸ø³öǰ20λµÄÏàËÆ»¯ºÏÎï~ ÒÑÓÐ1È˲ÎÓë
|
|
̼Æ×Êý¾Ý24.367,30.150,40.090,41.188,46.796,50.709,51.861,51.914,55.195,55.775,59.131,61.969,63.518,76.769,100.883,106.124,119.978,132.406,135.739,135.861,146.938,150.264,169.687 ë®´ú¼×´¼£¨ÈܼÁ·å£º47.146,47.284,47.429,47.566,47.711,47.856,47.993£© |
» ²ÂÄãϲ»¶
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ27È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
277 ÊýÒ»104£¬Ñ§Ë¶£¬Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
²ÄÁÏÀà284µ÷¼Á
ÒѾÓÐ44È˻ظ´
295·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ289 085602
ÒѾÓÐ29È˻ظ´
272·Ö²ÄÁÏ×ÓÇóµ÷¼Á
ÒѾÓÐ27È˻ظ´
ÖпÆÔº×Ü·Ö315Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á
ÒѾÓÐ30È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖúÈý¸ö»¯ºÏÎ̼Æ×£©µÄ΢Æ×Êý¾Ý¿â¼ìË÷½á¹û£¨ÏàËÆ¶Èǰ70%£©
ÒѾÓÐ8È˻ظ´
΢Æ×ÇóÖú£¬Ð»Ð»
ÒѾÓÐ4È˻ظ´
ÇóÖúÒ»»¯ºÏÎï΢Æ×Êý¾Ý½á¹¹
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖú£¬ÌṩÏàËÆ¶È¿¿Ç°µÄ5ƪÎÄÏ×£¬Ð»Ð»
ÒѾÓÐ10È˻ظ´
¼±Çó ÔÚÏßµÈ Î¢Æ×ÇóÖú
ÒѾÓÐ5È˻ظ´
΢Æ×ÇóÖú1¸ö»¯ºÏÎï
ÒѾÓÐ3È˻ظ´
¼±Çó΢Æ×¿â²éѯ£¡·Ç³£¸Ðл£¡
ÒѾÓÐ3È˻ظ´
ÇóÖúÁ½¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ3È˻ظ´
ÇóÖúÒ»¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý
ÒѾÓÐ4È˻ظ´
΢Æ× Ç󻯺ÏÎï
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖúÒ»»¯ºÏÎ£¡
ÒѾÓÐ5È˻ظ´
΢Æ×ÇóÖúÒ»»¯ºÏÎ£¡
ÒѾÓÐ5È˻ظ´
ÇóÖúÈý¸ö»¯ºÏÎ̼Æ×£©µÄ΢Æ×Êý¾Ý¿â¼ìË÷½á¹û£¨ÏàËÆ¶Èǰ20%£©
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ8È˻ظ´
΢Æ×Êý¾Ý¡£Ç󻯺ÏÎï½âÎö
ÒѾÓÐ3È˻ظ´
ÇóÖúͨ¹ý΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
ÇóÖú£º¸÷λ³æÒ¯£¬Çó΢Æ×£¡°Ë°ÙÀï¼Ó¼±£¡£¡£¡¿¿ÄãÃÇÁË£¡
ÒѾÓÐ19È˻ظ´
¿û»¨ÅɸßÊÖ
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 40 (СѧÉú)
- ½ð±Ò: 29.8
- É¢½ð: 20
- ºì»¨: 2
- Ìû×Ó: 229
- ÔÚÏß: 99.8Сʱ
- ³æºÅ: 2513202
- ×¢²á: 2013-06-19
- ÐÔ±ð: GG
- רҵ: ÌìȻҩÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
baoxianxie: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-01-27 22:45:16
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
baoxianxie: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-01-27 22:45:16
|
ÏàËÆ¶È£º %(ÏàËÆ¶È>=50%) ²éѯ½á¹û£º¹²²éµ½1¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) 1 . 2-hydroxy-3-methoxystrychnine ÏàËÆ¶È:52.1% Acta Pharmaceutica Sinica 1994 29 44-48 ANALYSIS OF SPECTRAL DATA FOR 13CNMR OF SIXTEEN STRYCHNOS ALKALOIDS BC Cai; H Wu; XW Yang; M Hattori and T Nainba Structure 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2015-01-26 12:39:50













»Ø¸´´ËÂ¥